Vienna Business Agency: Vienna Blossoms as a European Powerhouse in Life Sciences
With a remarkable 22% increase in industry revenues and a workforce now exceeding 49,000, Vienna is strengthening its…
aws: Life Sciences: Internationale Start-up Competition aws BoB - Best of Biotech 2025 feiert 25 Jahre
Bei aws BoB - Best of Biotech werden erste Ideen zu tragfähigen Geschäftskonzepten, Einreichungen bis 13.06.2025…
cogvis sichert sich siebenstelliges Investment der Raiffeisen-Landesbank Steiermark
Das Wiener Health-Tech Unternehmen cogvis baut internationale Vorreiterrolle im Bereich digitaler Pflegelösungen aus und…
XUND secures Pre-Series A: 6 million euros to strengthen European leadership in AI-powered healthcare
The investment, led by Lead Ventures and joined by J&T Ventures, strengthens XUND’s role in AI-powered healthcare. XUND…
Impuls für Exportnation Österreich: Octapharma erweitert Produktion für den Weltmarkt in Wien-Favoriten
Erweiterungsbau in nur 15 Monaten Bauzeit fertiggestellt
Kapazitäten für Sichtkontrolle, Verpackung und Logistik werden…
Somareality: EUR 2,6 Mio. Seed Investment
Wiener Deep Tech Unternehmen verzeichnet Finanzierungserfolg
UpNano Secures €7M Investment to Advance 2PP 3D Printing Technology
We're thrilled to announce the completion of our €7M Series A round co-led by aws Gründungsfonds, Novacapital and IGO…
invIOs raises €8.2 million in a Series A to finance pipeline progress in immuno-oncology
- Funding secures ongoing pipeline progress and achievement of preclinical and clinical milestones
- Oral small…
a:head secures pre-Series A funding and appoints Margarete Schramboeck and Madeline Lancaster to the Supervisory Board
a:head bio AG closed another 7-digit EUR financing round. This funding will further advance the company's mission to…
Aitiologic Emerges from Stealth Mode with Over €2.5M in Funding to Advance AI-Powered Liquid Biopsy Platform for Early Disease Detection
Aitiologic, a precision diagnostics start-up, today announced its emergence from stealth mode, unveiling plans to…
Flinn.ai secures 10 million euros in less than 18 months
The Vienna-based company will use this capital to revolutionize quality management in the medtech sector through AI…
Boehringer Ingelheim expands cancer research at its Vienna site
Inauguration of Angelika Amon research building in Vienna
OeAW and Boehringer Ingelheim Foundation establish new Institute for biomedical artificial intelligence in Vienna
Michael Bronstein leads the new AITHYRA Institute of the Austrian Academy of Sciences
Boehringer Ingelheim Foundation…
Valneva announces the success of its private placement raising approximately €60 million
Not to be released, published, distributed or circulated in the United States, Australia, Japan or any other…
F2G announces $100 million financing to advance late-stage development and commercialization of novel antifungal drug candidate Olorofim in the US
Financing is being led by new investor AMR Action Fund with strong participation from new investor ICG Life Sciences and…
APEIRON Biologics to be Acquired by Ligand Pharmaceuticals for USD 100 Million
Ligand also commits to invest up to USD 4 million in APEIRON spin-off, invIOs
Laerdal and SIMCharacters Announce Exclusive Worldwide Distribution Partnership for SIMCharacters Innovative Neonatal Simulation Solutions
Laerdal Medical, a global leader in healthcare simulation solutions, is excited to unveil its exclusive worldwide…
Align Technology completes acquisition of Cubicure, a pioneer of direct 3D printing solutions for polymer additive manufacturing
Align continues to innovate and invest in technologies that enable the next generation of direct 3D printed products,…
Hookipa Pharma Announces $21.25 Million Equity Investment from Gilead Sciences
- Gilead purchased 15 million newly issued shares of common stock at a price of $1.4167 per share
- Following the close…
Biomay Announces Expansion of its GMP-Facilities to Offer mRNA Manufacturing and Aseptic Filling Services
Biomay, a Vienna based biotech manufacturer, announced a facility extension and is now able to expand its…
Valneva Announces U.S. FDA Approval of World’s First Chikungunya Vaccine, IXCHIQ®
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the U.S. Food and Drug…
HeartBeat.bio raises € 4.5 million in Pre-Series A financing to drive development of organoid screening platform for cardiac drug discovery
- New funds committed to market-ready development of HeartBeat.bio’s unique 3D human tissue-based Cardioid Drug…
Groundbreaking: Takeda builds lab of the future in Vienna
Together with high-ranking representatives from government, business and academia, Takeda today held a symbolic…
Spatenstich in Wien-Favoriten: Octapharma baut Produktionsstandort stark aus
• Erweiterung Haberkornhalle wichtiger Meilenstein im Ausbauprogramm
• Produktionserweiterung, um Wachstumserwartungen…
Vienna-based PIUR IMAGING secures €4.9 Million to expand its AI-driven tomographic 3D to the US
PIUR IMAGING, a medical device company that enables access to affordable high-quality healthcare through AI-driven…
SanusX and Biome Diagnostics forge strategic partnership
SanusX and Biome Diagnostics forge a strategic partnership for growth in cutting-edge diagnostic procedures.
Holistic…
contextflow approved for EIC Accelerator Equity Investment
We are beyond thrilled to announce that contextflow’s application for the European Innovation Council (EIC) Accelerator…
Vienna-based nyra health raises €4.5 million in Seed to further advance its digital neuro-therapy
Nyra Health: "We are thrilled to officially announce our oversubscribed 4.5m seed round co-led by MassMutual Ventures…
Boehringer Ingelheim feiert Dachgleiche beim neuen Krebsforschungsgebäude
Nach dem Baubeginn im Juli letzten Jahres setzt Boehringer Ingelheim einen Meilenstein beim Bau des neuen…
HOOKIPA Pharma Announces Pricing of $50.0 Million Public Offering of Common Stock and Non-Voting Convertible Preferred Stock
HOOKIPA Pharma Inc. (Nasdaq: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its…
Takeda: Neuer Dengue-Fieber Impfstoff wird in Wien geprüft
Feierliche Eröffnung der Erweiterung des Global Pathogen Safety Labors von Takeda
Proxygen announces collaboration and license agreement with MSD
Proxygen, a leader in the discovery and development of molecular glue degraders, announced today a multi-year research…
ViennaLab Diagnostics partnered with Euformatics and Oncompass Medicine to win a major contract for a liquid biopsy NGS solution
The new year has started and we jumped into it with a new pre-commercial procurement contract for an R&D service from…
QMD Services obtains designation as a Notified Body for in vitro diagnostic devices
Milestone for the Medical Device Industry
Nutrients from CO2: Arkeon Increases its Capitalization to €10+ Million in Additional Fundraiser
Austria-based ingredients startup Arkeon turns CO2 into next-generation protein ingredients and raises another €4+…
Glovemaker HARPS Acquires Semperit’s Medical Business For EUR115 Million
HARPS Global Pte Ltd (“HARPS Global”) and Semperit Technische Produkte GmbH (“Semperit”) have reached an agreement on…
X4 Pharmaceuticals Prices $65.0 Million Public Offering
X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel small-molecule therapeutics…
aws: Die besten Start-ups, Spin-offs, Prototypen und Female Entrepreneurs des Landes wurden mit dem Gründungspreis PHÖNIX ausgezeichnet
Der Gründungspreis PHÖNIX macht herausragenden Wissenstransfer sichtbar und prämiert die besten Gründungsprojekte. Heuer…
HOOKIPA announces strategic collaboration and license agreement with Roche to develop novel arenaviral immunotherapy for KRAS-mutated cancers
- Roche to receive license for HOOKIPA’s HB-700 program and option to license a second undisclosed novel arenaviral…
aws Best of Biotech 2022: Auszeichnung der besten Life Science Geschäftskonzepte
Am 19. Oktober wurden im Rahmen einer Galaveranstaltung die Gewinner der 10. Ausgabe der Start-up Competition aws Best…
Lithoz acquires CerAMing, expands into third ceramic 3D printing technology
With the acquisition of CerAMing and its LSD printing technology, Lithoz now fully covers all strategically relevant…
HeartBeat.bio collaborates with Boehringer Ingelheim to investigate cardiac organoids for the development of new treatments for people with heart diseases
HeartBeat.bio AG has entered a collaboration with Boehringer Ingelheim for the investigation of human cardiac organoids…
Valneva announces closing of upsized €102.9 million global offering
The financing was led by US healthcare specialist Deep Track Capital and also included existing shareholders such as…
Healthtech start-up XUND raises €6m – the one of the largest seed rounds to date in Austria
Vienna-based healthtech start-up XUND has raised EUR 6 million for its AI-powered API – the only one certified as a…
LIVIN farms secures EUR 6 Million Series A investment to turn food waste into valuable protein
Vienna based startup LIVIN Farms has raised a EUR 6 Million Series A round led by Venture Investor Peter Luerssen. LIVIN…
heartbeat.bio and molecular devices announe collaboration to automate and scale cardiac organoids for high-throughput screening in drug discovery
HeartBeat.bio AG, a biotech company developing cardiac organoids (Cardioids) for drug discovery, and Molecular Devices,…
Springer Nature Health acquires Austrian health tech start-up, Medbee
App from leading online network for doctors to be expanded to German medical professionals
Valneva gibt die Auslieferung seines inaktivierten COVID-19 Ganzvirusimpfstoffs in Österreich bekannt
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), ein spezialisiertes Impfstoffunternehmen, gab heute bekannt, dass die…
F2G Announces $70 Million Financing to Advance Development and Commercialization of New Antifungal Agent Olorofim
New Investment from Forbion and Sofinnova Partners
QUANTRO Therapeutics collaborates with Boehringer Ingelheim to develop drug candidates interfering with transcriptional regulators
QUANTRO Therapeutics today announced that they have entered a three-year collaboration, option and license agreement…
Biosynth Carbosynth to offer Enzyme Development following Acquisition of EUCODIS Bioscience
Expanded biological products and custom services offer for Life Science customers.
AOP Health erforscht ab sofort neue Behandlungsmöglichkeiten für Leukämie
Die Unternehmensgruppe AOP Health hat im Juli eine Vereinbarung für die Weiterentwicklung einer neu entdeckten…
Boehringer Ingelheim errichtet neues Forschungsgebäude in Wien
- Spatenstich am 26. Juli – Fertigstellung geplant für 2024
- Investitionsvolumen rund 60 Mio. EUR
- Stärkung des…
UpNano: 2PP 3D-Printing: Fresh capital boosts innovation and use in serial production
UpNano further strengthens R&D and US expansion with capital increase
Valneva Receives Marketing Authorization in Europe for Inactivated Whole-Virus COVID-19 Vaccine VLA2001
VLA2001 becomes the first COVID-19 vaccine to receive a standard marketing authorization in Europe
Proxygen Announces Strategic Collaboration with Merck to Develop Molecular Glue Degraders
Proxygen, a leader in the discovery and development of molecular glue degraders, announced today that the company has…
BMDW: Schramböck: 50 Millionen Euro Investitionspaket für den heimischen Pharmastandort
FFG wird 50 Millionen Euro starkes Programm umsetzen - Österreichische Betriebe forschen für die Gesundheit Österreichs
Wiener Life-Science-Unternehmen Valneva präsentiert Corona-Impfstoff aus Wien
13,3 Milliarden Umsatz, 600 ansässige Organisationen und 41.000 Arbeitsplätze: Das sind die aktuellsten Kennzahlen der…
CellEctric closes first financing round with IST cube and other private investors
The Viennese spin-off from AIT Austrian Institute of Technology develops an electrodynamic cell manipulation platform…
Roche subsidiary RoX Health invests six-figure sum in Viennese healthtech start-up XUND
XUND combines medical knowledge with proven algorithms to create high-quality solutions for the digital health market.…